Dividends Inside 
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock
BGMSP
$1.40 (+ $0.00 + 0.00%)
Last updated: 2026-07-17 23:53 UTC
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock trades under ticker BGMSP on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US23254L2079, CUSIP 23254L207.
Related researchBGMSP stock priceBGMSP share priceBGMSP dividend historyBGMSP dividend yieldCyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock dividend historyCyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock dividend yield23254L207Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred StockCyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock share price
About the Company
Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It also researches and develops pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
Price History
Latest News for BGMSP
BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
KUALA LUMPUR, MALAYSIA, May 14, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced first quarter financial results and provided a business update. Highlights of the first quarter ended March 31, 2026, or in some cases shortly thereafter, include: ●In March, trading of the Company’s 6% Convertible Exchangeable Preferred Stock (
Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments
Company Also Announces $7 Million Strategic Investment and Associated Leadership TransitionSUMMIT, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a consumer products company, today announced separate transactions related to its previously announced Strategic Alternative Process. Sale of E-Commerce Brand Portfolio (the “Asset Sale”) The Company has signed a definitive agreement with Trademark Global, LLC (“Trademark”) for the sale of assets ass
BIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
KUALA LUMPUR, MALAYSIA, March 30, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. ("BGMS," the "Company" or “we,” formerly Cyclacel Pharmaceuticals, Inc.) (NASDAQ: BGMS), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced fourth quarter and full year 2025 financial results and provided a business update. “2025 was a productive year for BGMS, marked by the acquisition of Fitters Sdn. Bhd., a fire safety materials a
Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update
KUALA LUMPUR, Malaysia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS, NASDAQ: BGMSP; "BGMS" or the "Company" (formerly Cyclacel Pharmaceuticals, Inc.)), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced third quarter financial results and provided a business update. Highlights of the third quarter ended September 30, 2025, or in some cases shortly thereafter, include: In July, the Compan